Autologous haematopoietic stem cell transplantation (AHSCT) is an emerging therapeutic option for refractory Crohn’s disease (CD). The ASTIC trial of AHSCT failed to meet its stringent composite primary endpoint, but 1-year follow-up data demonstrate sustained efficacy. The real-world use and outcomes of AHSCT for CD are unknown. Using the EBMT registry, we evaluated long-term outcomes for patients (pts) undergoing AHSCT for CD in Europe
IMPORTANCE: Case reports and series suggest hematopoietic stem cell transplantation (HSCT) may benef...
Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership (project number 15/17...
IMPORTANCE: Case reports and series suggest hematopoietic stem cell transplantation (HSCT) may benef...
Background and Aims Autologous haematopoietic stem cell transplantation [AHSCT] is a therapeutic opt...
Despite the major recent progress in the treatment of Crohn’s disease [CD], there is a subset of pat...
Despite the major recent progress in the treatment of Crohn's disease (CD), there is a subset of pat...
Despite the major recent progress in the treatment of Crohn's disease (CD), there is a subset of pat...
BACKGROUND AND AIMS: Autologous haematopoietic stem cell transplantation [AHSCT] is a therapeutic op...
IMPORTANCE Case reports and series suggest hematopoietic stem cell transplantation (HSCT) may benefi...
Patients with treatment refractory Crohn’s disease (CD) suffer debilitating symptoms, poor quality o...
Patients with treatment refractory Crohn’s disease (CD) suffer debilitating symptoms, poor quality o...
Background and Aims Autologous haematopoietic stem cell transplantation [AHSCT] is a therapeutic opt...
Background Intestinal inflammation in Crohn’s disease (CD) is caused by mucosal immune system reacti...
Background Intestinal inflammation in Crohn’s disease (CD) is caused by mucosal immune system reacti...
Autologous haematopoietic stem cell transplantation (HSCT) with CD34(+) cell selection has recently ...
IMPORTANCE: Case reports and series suggest hematopoietic stem cell transplantation (HSCT) may benef...
Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership (project number 15/17...
IMPORTANCE: Case reports and series suggest hematopoietic stem cell transplantation (HSCT) may benef...
Background and Aims Autologous haematopoietic stem cell transplantation [AHSCT] is a therapeutic opt...
Despite the major recent progress in the treatment of Crohn’s disease [CD], there is a subset of pat...
Despite the major recent progress in the treatment of Crohn's disease (CD), there is a subset of pat...
Despite the major recent progress in the treatment of Crohn's disease (CD), there is a subset of pat...
BACKGROUND AND AIMS: Autologous haematopoietic stem cell transplantation [AHSCT] is a therapeutic op...
IMPORTANCE Case reports and series suggest hematopoietic stem cell transplantation (HSCT) may benefi...
Patients with treatment refractory Crohn’s disease (CD) suffer debilitating symptoms, poor quality o...
Patients with treatment refractory Crohn’s disease (CD) suffer debilitating symptoms, poor quality o...
Background and Aims Autologous haematopoietic stem cell transplantation [AHSCT] is a therapeutic opt...
Background Intestinal inflammation in Crohn’s disease (CD) is caused by mucosal immune system reacti...
Background Intestinal inflammation in Crohn’s disease (CD) is caused by mucosal immune system reacti...
Autologous haematopoietic stem cell transplantation (HSCT) with CD34(+) cell selection has recently ...
IMPORTANCE: Case reports and series suggest hematopoietic stem cell transplantation (HSCT) may benef...
Efficacy and Mechanism Evaluation (EME) Programme, an MRC and NIHR partnership (project number 15/17...
IMPORTANCE: Case reports and series suggest hematopoietic stem cell transplantation (HSCT) may benef...
Add to ORKG